Quantcast
Last updated on April 18, 2014 at 16:52 EDT

Latest National Institute of Neurological Disorders and Stroke Stories

2013-05-20 12:26:47

Recognizing the signs and taking immediate action - calling 9-1-1 - can dramatically decrease the impact of a stroke BETHESDA, Md., May 20, 2013 /PRNewswire/ -- During Stroke Awareness Month this May, the National Institute of Neurological Disorders and Stroke's (NINDS) Know Stroke campaign is urging all Americans to "make the stroke call" by learning the signs of stroke and sharing them across social media platforms. NINDS has produced a series of infographics to increase...

2013-05-06 20:32:30

NIH-supported study suggests cell therapy may be a viable approach More than two million people in the United States suffer from epilepsies, a group of neurological disorders caused by abnormal nerve cell firing in the brain which often produce debilitating seizures. Although anti-epileptic drugs and other therapies reduce seizures in about two-thirds of patients, the remaining one-third do not respond to any form of therapy and those who take drugs can experience harmful side effects. NIH...

2013-04-03 23:04:27

Sports Health and Research Program a Partnership with NIH and NFL Bethesda, MD (PRWEB) April 04, 2013 The FNIH today announced that the Sports and Health Research Program (SHRP) is seeking NIH grant proposals from experts in the field to study the detection, diagnosis, treatment and prevention of sports-related brain injuries. The SHRP -- sponsored by the NFL in collaboration with the NIH and announced last September — is conducting research focused on the long-term health effect of...

Implantable Device Reduces Seizures In Epileptic Patients
2013-02-18 09:50:09

Lawrence LeBlond for redOrbit.com - Your Universe Online A medical device company recently received funding from a branch of the National Institutes of Health (NIH) to conduct a new two-Phase clinical trial for an internally-implanted electronic device that may help treat epilepsy. NeuroSigma Inc., the company behind the device, is basing the new trial on evidence of another similar device, an electronic patch that has been shown to reduce symptoms of depression by up to 50 percent....

2013-02-06 10:11:07

A training regimen to adjust the body's motor reflexes may help improve mobility for some people with incomplete spinal cord injuries, according to a study supported by the National Institutes of Health. During training, the participants were instructed to suppress a knee jerk-like reflex elicited by a small shock to the leg. Those who were able to calm hyperactive reflexes — a common effect of spinal cord injuries — saw improvements in their walking. The study was led by...

2013-02-04 08:25:15

LOS ANGELES, Feb. 4, 2013 /PRNewswire/ -- NeuroSigma, Inc., a California-based medical device company, today announced it received a Notice of Award, for a Fast Track Small Business Innovation Research (SBIR) grant, from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH). Phase I of the project is budgeted in the amount of $600,000, with $3 Million budgeted for Phase II, subject to the availability of funds and satisfactory progress...

2012-12-20 20:22:15

24-hospital trial shows inexpensive education effort increases safe tPA use ANN ARBOR, Mich., Dec. 20, 2012 /PRNewswire-USNewswire/ -- From the moment a stroke occurs, patients must race against the clock to get treatment that can prevent lasting damage. Now, a new study shows the promise - and the challenges - of getting them state-of-the-art treatment safely at their local hospital, saving precious minutes. The results come from an effort that tested methods to improve delivery of a...

2012-12-13 08:26:13

MIAMI, Dec. 13, 2012 /PRNewswire/ -- Insero Health, Inc., a company developing natural compounds to address unmet medical needs in neurological disorders, today announced that it has completed a Phase Ib trial of its lead compound INS001 in patients with drug-resistant epilepsy. Insero also reported that two key US patents licensed from Harvard University have issued, and the company announced the formation of its Scientific Advisory Board (SAB). INS001, also known as huperzine A, is a...

2012-11-07 12:26:53

NEW YORK, Nov. 7, 2012 /PRNewswire-USNewswire/ -- Today, The Michael J. Fox Foundation (MJFF) and the NIH National Institute of Neurological Disorders and Stroke (NINDS) are announcing a first-of-its-kind collaboration called BioFIND, a multi-site study exclusively focused on identifying Parkinson's disease (PD) biomarkers. "BioFIND is a novel public-private partnership to accelerate the search for better Parkinson's disease treatments," says Mark Frasier, Ph.D., vice president of research...

2012-10-10 21:35:50

Improved study design and data sharing are expected to speed therapy development A workshop sponsored by NIH's National Institute of Neurological Disorders and Stroke (NINDS) has produced a set of consensus recommendations to improve the design and reporting of animal studies. By making animal studies easier to replicate and interpret, the workshop recommendations are expected to help funnel promising therapies to patients. Biomedical research involving animals has led to life-saving...